Romlusevimab
Romlusevimab Basic information
- Product Name:
- Romlusevimab
- Synonyms:
-
- Romlusevimab
- Research Grade Romlusevimab (DVV00312)
- Research Grade Romlusevimab
- CAS:
- 2509447-08-7
- MW:
- 0
- Mol File:
- Mol File
More
Less
Romlusevimab Chemical Properties
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Romlusevimab Usage And Synthesis
Uses
Romlusevimab (BRII-198) is a neutralizing recombinant human IgG1 monoclonal antibody against the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)[1][2].
in vivo
Romlusevimab (10 mg/kg, ip, single) in combination with Amubarvimab (HY-P99435) protects animals from Omicron infection in a mouse model of SARS-CoV-2 infection[1].
References
[1] Hoy SM. Amubarvimab/Romlusevimab: First Approval. Drugs. 2022 Aug;82(12):1327-1331. DOI:10.1007/s40265-022-01759-3
[2] Ji Y, et al. Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2. Front Immunol. 2022 Sep 14;13:980435. DOI:10.3389/fimmu.2022.980435
RomlusevimabSupplier
ShangHai Biochempartner Co.,Ltd
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
Guangzhou Hongyuan Chemical Co.,Ltd
- Tel
- 15817493340
- 981810490@qq.com
Wuhan Chemstan Biotechnology Co., Ltd.
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
TargetMol Chemicals Inc.
- Tel
- 4008200310
- marketing@tsbiochem.com
Biolab Reagents
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com